A pore-forming toxin interacts with a GPI-anchored protein and causes vacuolation of the endoplasmic reticulum.
In this paper, we have investigated the effects of the pore-forming toxin aerolysin, produced by Aeromonas hydrophila, on mammalian cells. Our data indicate that the protoxin binds to an 80-kD glycosyl-phosphatidylinositol (GPI)-anchored protein on BHK cells, and that the bound toxin is associated with specialized plasma membrane domains, described as detergent-insoluble microdomains, or cholesterol-glycolipid "rafts." We show that the protoxin is then processed to its mature form by host cell proteases. We propose that the preferential association of the toxin with rafts, through binding to GPI-anchored proteins, is likely to increase the local toxin concentration and thereby promote oligomerization, a step that it is a prerequisite for channel formation. We show that channel formation does not lead to disruption of the plasma membrane but to the selective permeabilization to small ions such as potassium, which causes plasma membrane depolarization. Next we studied the consequences of channel formation on the organization and dynamics of intracellular membranes. Strikingly, we found that the toxin causes dramatic vacuolation of the ER, but does not affect other intracellular compartments. Concomitantly we find that the COPI coat is released from biosynthetic membranes and that biosynthetic transport of newly synthesized transmembrane G protein of vesicular stomatitis virus is inhibited. Our data indicate that binding of proaerolysin to GPI-anchored proteins and processing of the toxin lead to oligomerization and channel formation in the plasma membrane, which in turn causes selective disorganization of early biosynthetic membrane dynamics.
Abrami
L
L
Department of Biochemistry, University of Geneva, 1211 Geneva, Switzerland.
Fivaz
M
M
Glauser
P E
PE
Parton
R G
RG
van der Goot
F G
FG
D000818:Animals; D001427:Bacterial Toxins / Q000378:metabolism* / Q000494:pharmacology*; D001692:Biological Transport; D020126:Brefeldin A; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism* / Q000502:physiology; D002463:Cell Membrane Permeability; D002470:Cell Survival; D020756:Coatomer Protein; D006224:Cricetinae; D003517:Cyclopentanes / Q000378:metabolism; D010450:Endopeptidases / Q000378:metabolism; D004721:Endoplasmic Reticulum / Q000378:metabolism / Q000648:ultrastructure*; D017261:Glycosylphosphatidylinositols / Q000378:metabolism*; D006056:Golgi Apparatus / Q000378:metabolism / Q000648:ultrastructure; D008562:Membrane Glycoproteins; D008564:Membrane Potentials; D008565:Membrane Proteins; D008854:Microscopy, Electron; D052899:Pore Forming Cytotoxic Proteins; D011499:Protein Processing, Post-Translational; D014617:Vacuoles / Q000648:ultrastructure*; D014759:Viral Envelope Proteins / Q000096:biosynthesis / Q000378:metabolism
D001427:Bacterial Toxins; D020756:Coatomer Protein; D003517:Cyclopentanes; C028391:G protein, vesicular stomatitis virus; D017261:Glycosylphosphatidylinositols; D008562:Membrane Glycoproteins; D008565:Membrane Proteins; D052899:Pore Forming Cytotoxic Proteins; D014759:Viral Envelope Proteins; C107096:proaerolysin; D020126:Brefeldin A; D010450:Endopeptidases